Maynard Um
-
-
-
-
-
-
-
Sanara MedTech reports revenue growth, provides 2026 guidance
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Sanara MedTech (SMTI)
-
-
-
-
-
-
-
Sanara MedTech (SMTI) Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
-
-
-
-
-
-
422,375 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

